Your browser doesn't support javascript.
loading
Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome.
Pical-Izard, Caroline; Crocchiolo, Roberto; Granjeaud, Samuel; Kochbati, Eloise; Just-Landi, Sylvaine; Chabannon, Christian; Frassati, Coralie; Picard, Christophe; Blaise, Didier; Olive, Daniel; Fauriat, Cyril.
Afiliação
  • Pical-Izard C; Inserm, U1068, Centre Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, Aix-Marseille University, Marseille, France.
  • Crocchiolo R; Bone Marrow Transplantation Unit, Onco-Hematology Department, Institut Paoli-Calmettes, Marseille, France; Istituto Clinico Humanitas, Rozzano, Italy.
  • Granjeaud S; Inserm, U1068, Centre Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, Aix-Marseille University, Marseille, France.
  • Kochbati E; Inserm, U1068, Centre Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, Aix-Marseille University, Marseille, France.
  • Just-Landi S; Inserm, U1068, Centre Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, Aix-Marseille University, Marseille, France.
  • Chabannon C; Inserm, U1068, Centre Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, Aix-Marseille University, Marseille, France; Centre de Thérapie Cellulaire, Département de Biologie du Cancer, Institut Paoli-Calmettes, Marseille, France; Inserm CIC-1049, Centre d'Investigations
  • Frassati C; Histocompatibility Laboratory, UMR 7268 ADÉS, Aix-Marseille Université/EFS/CNRS, Marseille, France.
  • Picard C; Histocompatibility Laboratory, UMR 7268 ADÉS, Aix-Marseille Université/EFS/CNRS, Marseille, France.
  • Blaise D; Inserm, U1068, Centre Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, Aix-Marseille University, Marseille, France; Istituto Clinico Humanitas, Rozzano, Italy.
  • Olive D; Inserm, U1068, Centre Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, Aix-Marseille University, Marseille, France.
  • Fauriat C; Inserm, U1068, Centre Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, Aix-Marseille University, Marseille, France. Electronic address: cyril.fauriat@inserm.fr.
Biol Blood Marrow Transplant ; 21(3): 429-39, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25579888
ABSTRACT
Recent advances in the development of reduced-intensity conditioning (RIC) have allowed a broader range of patients to access allogeneic hematopoietic stem cell transplantation (HSCT). Reconstitution of an effective immune system post-transplant, including natural killer (NK) cells, is critical for both tumor control and infectious disease control or prevention. The development and functions of NK cells in such settings remain elusive. Here we analyzed NK cell development in HLA-matched HSCT from related or unrelated donors, after RIC that included antithymocyte globulin (N = 45 patients). Our data reveal that NK cells quickly recover after RIC-HSCT, irrespective of donor type. Rapidly re-emerging NK cells, however, remain immature for more than 6 months. Effector functions resemble that of immature NK cells because they poorly produce IFN-γ and TNF-α in response to target cell stimulation, despite a rapid acquisition of degranulation ability and MIP-1ß production. Strikingly, rapid reconstitution of cytokine production correlates with a lower relapse incidence (P = .01) and a better survival rate (P < .0001) at 1 year post-transplant, whereas degranulation capacity was associated with less relapse (P = .05). Our study demonstrates rapid quantitative reconstitution of the NK cell compartment despite administration of potent immune suppressive drugs as part of the conditioning regimen and after transplantation. However, there is a prolonged persistence of functional defects, the correction of which positively correlates with clinical outcome.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Citocinas / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Recuperação de Função Fisiológica Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Citocinas / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Recuperação de Função Fisiológica Idioma: En Ano de publicação: 2015 Tipo de documento: Article